Pfizer and Moderna will likely seek emergency use authorization from the US Food and Drug Administration for their coronavirus vaccines within the next few weeks , Moncef Slaoui , chief adviser to Operation Warp Speed , said Friday at a White House briefing . 
If approved , vaccinations could begin in December , he said . 
Pfizer said Monday that its coronavirus vaccine appears to be more than 90 % effective , based on early data . 
Slaoui called the announcement " thrilling , " adding that it demonstrated that " vaccination is possible against Covid 19 . " 
Moderna announced this week it had enough coronavirus cases among its trial participants to complete its first interim analysis . 
Slaoui added that if other vaccines are approved , the number of vaccinations per month could increase . 
